Rockefeller Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.7M Buy
33,849
+14,188
+72% +$6.78M 0.03% 474
2025
Q4
$11.4M Buy
19,661
+1,210
+7% +$618K 0.02% 623
2025
Q3
$8.46M Buy
18,451
+503
+3% +$188K 0.02% 674
2025
Q2
$5.43M Buy
17,948
+339
+2% +$101K 0.01% 764
2025
Q1
$5.83M Sell
17,609
-601
-3% -$197K 0.01% 697
2024
Q4
$5.62M Buy
18,210
+122
+0.7% +$34.3K 0.01% 692
2024
Q3
$3.84M Sell
18,088
-1,000
-5% -$256K 0.01% 788
2024
Q2
$5.35M Sell
19,088
-16,073
-46% -$3.83M 0.02% 668
2024
Q1
$9.39M Buy
35,161
+2,121
+6% +$500K 0.03% 522
2023
Q4
$7.64M Buy
33,040
+14,926
+82% +$2.61M 0.03% 534
2023
Q3
$2.65M Buy
18,114
+6,289
+53% +$1.18M 0.01% 743
2023
Q2
$2.73M Buy
11,825
+1,735
+17% +$470K 0.01% 746
2023
Q1
$2.44M Buy
+10,090
New +$2.75M 0.01% 748

Other funds holding MDGL